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Although exercise prevents cardiovascular disease and mortality, vigorous exercise and endurance 
athletics can cause atrial fibrillation (AF). However, no large cohort study has assessed the relationship 
between physical activity and AF in the general population. We assessed the effect of physical activity 
at different energy expenditures on the incidence of AF. We studied 501,690 individuals without pre-
existing AF (mean age, 47.6 ± 14.3 years; 250,664 women [50.0%]) included in the Korean National 
Health Insurance Service database. The physical activity level was assessed using a standardized self-
reported questionnaire at baseline. During a median follow-up of 4 years, 3,443 participants (1,432 
women [41.6%]) developed AF. The overall incidence of AF at follow-up was 1.79 per 1,000 person-
years. The subjects who met the recommended physical activity level (500–1,000 metabolic equivalent 
task [MET] minutes/week) had a 12% decreased AF risk (adjusted hazard ratio [HR]: 0.88, 95% 
confidence interval [CI]: 0.80–0.97), but not the insufficiently (1–500 MET-minutes/week; HR: 0.94, 95% 
CI: 0.86–1.03) and highly active subjects (≥1,000 MET-minutes/week; HR: 0.93, 95% CI: 0.85–1.03). The 
recommended minimum key target range of physical activity level was associated with the maximum 
benefit for reduced AF risk in the general population. The dose-response relationship between physical 
activity level and AF risk showed a U-shaped pattern. Although exceeding the key target range 
attenuated this benefit, it did not increase the AF risk beyond that during inactivity.
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide and can increase the risk of stroke, 
heart failure, dementia, and mortality1–3. The lifetime AF risk is one in four individuals aged >40 years4. Its prev-
alence will increase rapidly with the aging society, and the public health burden imposed by AF and AF-related 
morbidity is enormous. The population attributable risk of AF for lifestyle based risk factors is more than half5. 
Regular physical activity has favorable effects on cardiovascular risk factors, including significant reductions in 
cardiovascular morbidity and mortality for those meeting the recommended level.
The potential benefit of regular physical activity in reducing AF risk may be considerable. However, the rela-
tionship between physical activity level and AF risk remains unclear; the reported relationship varied among 
studies. Moderate physical activity is related to reduced AF risk, while high-intensity or endurance exercise is 
associated with increased AF risk in younger athletes and middle-aged men6–10. Thus, the effect of different phys-
ical activity levels on the incidence of AF varies. However, no eligible studies have addressed whether the public 
health guideline-recommended physical activity level can positively affect the AF risk. Moreover, the optimal 
target range for AF prevention remains undefined.
In this study, we evaluated the association of physical activity level and new-onset AF in a community-based 
database in Korea, which includes >500,000 individuals who underwent health examinations. Moreover, we 
assessed the effect of different physical activity levels on the incidence of AF and aimed to suggest the optimal 
target range of physical activity for AF prevention.
1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of 
Korea. 2Division of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea. Moo-
Nyun Jin and Pil-Sung Yang contributed equally. Correspondence and requests for materials should be addressed to 
B.J. (email: cby6908@yuhs.ac)
Received: 7 May 2019
Accepted: 23 August 2019
Published: xx xx xxxx
open
2Scientific RepoRtS |         (2019) 9:13270  | https://doi.org/10.1038/s41598-019-49686-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
Methods
Data source. This study was based on the Korean National Health Insurance Service (NHIS) sample cohort 
(from 2002 to 2013) database released in 2015. The NHIS manages all Korean health service databases as a sin-
gle-insurer system. The sample cohort was extracted via probability sampling from all beneficiaries of the NHIS 
and National Medical Aid depending on the entire national cohort information. The sample cohort database con-
sisted of the dataset of the sociodemographic information of the beneficiaries; medical claims dataset, including 
information on the diagnosis based on the 10th revision of the International Classification of Disease (ICD-10) 
codes, treatment, and admission; and National Health Screening dataset. The National Health Screening dataset 
comprised a health check-up database conducted for the entire Korean population from 2002 to 2013 by the 
National Health Insurance Corporation. The National Health Screening Program included chest X-ray, blood 
test, physical examination, anthropometric measurement, and use of a questionnaire related to physical activity. 
Approximately 70% of the entire cohort underwent a national health screening program11. The death registration 
database of the Korea National Statistical Office, including the date and cause of the death, was linked with the 
NHIS cohort database. Every population in the sample cohort was linked by the Korean social security numbers, 
and all social security numbers were deleted after constructing the cohort by providing serial numbers to prevent 
leakage of personal information. This study was approved by the Institutional Review Board (IRB) of Yonsei 
University College of Medicine in Seoul, Republic of Korea. The IRB waived the requirement to obtain informed 
consent, and this study was conducted in accordance with the tenets of the Declaration of Helsinki.
Study population. This study investigated adults without AF aged >18 years receiving the National Health 
Screening Program in 2009 among the total population included in the sample cohort. Data of 501,690 par-
ticipants were available for analyses. To include only newly diagnosed AF, we selected all patients with AF not 
diagnosed during the 3-year blanking period from January 2002 to December 2004. AF was defined according 
to ICD-10 code I48 and presence of one hospitalization or two outpatient visits. To evaluate the accuracy of our 
definition of AF, we conducted a validation study in two hospitals with 628 randomly selected patients with ICD-
10 code I48. Their electrocardiograms were reviewed by two physicians. The patients were ascertained to have 
AF, with a positive predictive value of 94.1%12,13. The participants were followed up at the time of incident AF, 
disqualification by the NHIS (mortality or immigration), or end of the study (December 31, 2013). The details 
regarding profile of this cohort and definition of AF have been well described in previously published articles11–15.
Physical activity level assessment. The National Health Screening Program included health examination 
and interview. The health interview included a self-administered standardized questionnaire for ascertaining 
the physical activity status16,17. Each participant was asked to report the frequency of physical activity weekly in 
three categories: vigorous (20-minute increments), moderate (30-minute increments), and walking (30-minute 
increments). Vigorous-intensity physical activity was defined as intense exercise that causes severe shortness of 
breath such as running. Moderate-intensity physical activity was defined as exercise that causes mild shortness 
of breath such as brisk walking and bicycling at a usual speed. Walking was defined as usual-pace walking for at 
least 10 minutes at a time, including transportation. Each type of activity was assigned a metabolic equivalent task 
(MET) score based on the energy cost18,19. We computed the energy expended in each activity by multiplying the 
associated MET score by the minutes on the activity and summed the energy expended across the moderate- to 
vigorous-intensity activities to estimate the total energy expenditure per week.
The participants were stratified on the basis of their weekly physical activity levels as follows: (1) inactive 
group: no leisure-time physical activity (LTPA) beyond basic movements; (2) insufficiently active group: having 
less than the key guideline target range (1–500 MET-minutes/week); (3) active group: meeting the key guideline 
target range (500–1,000 MET-minutes/week); and (4) highly active group: exceeding the key guideline target 
range (>1,000 MET-minutes/week)20,21.
Statistical analysis. Descriptive statistics were used to characterize the baseline characteristics and comor-
bidities. The values were presented as means ± standard deviations or as percentages, as appropriate. Cox pro-
portional hazard regression was used to assess the association between AF and LTPA. Models for clinical variable 
adjustments were used to assess the association. A multivariable model was adjusted for age, sex, body mass 
index (BMI), heart failure, hypertension, diabetes, previous myocardial infarction (MI), prior stroke or transient 
ischemic attack, chronic kidney disease (CKD), smoking, and alcohol drinking. To assess the dose-response rela-
tionship LTPA and mortality, we used restricted cubic spline model. We further examined the physical activity 
levels by separating moderate-intensity and vigorous-intensity activities and creating mutually adjusted models. 
We also stratified them by potential effect modifiers of age, sex, BMI, waist circumflex, heart failure, hypertension, 
blood pressure, diabetes, CKD, previous MI, dyslipidemia, smoking, and alcohol drinking. A p-value of <0.05 
was considered statistically significant. Statistical analysis was performed using the Statistical Package for Social 
Sciences version 23.0 (SPSS Inc., Chicago, IL, USA) and R version 3.4.4 (R Foundation for Statistical Computing, 
Vienna, Austria).
Results
Baseline characteristics. In total, 501,690 participants (50% women) with a mean age of 47.6 ± 14.3 years 
were included in the analyses. The baseline characteristics of the study participants stratified according to their 
LTPA are compared in Table 1. With regard to physical activity level, 25.0% of the participants were inactive; 
31.4% performed insufficiently active LTPA (1–500 MET-minutes/week); 26.5% performed active LTPA (500–
1,000 MET-minutes/week); and 17.2% performed highly active LTPA (>1,000 MET-minutes/week).
Physical activity and AF. During a median follow-up of 4 years, 3,443 participants (1,432 women [41.6%]) 
developed AF. The overall incidence of AF at follow-up was 1.79 per 1,000 person-years. The cumulative incidence 
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of AF according to physical activity levels presented in Supplementary Fig. 1. When stratified by physical activity 
level, the incidence was 2.27, 1.52, 1.56, and 1.91 per 1,000 person-years in the inactive, insufficiently active, 
active, and highly active groups, respectively (Table 2). There was a U-shaped relationship between physical activ-
ity level and AF risk (Fig. 1). The active group (500–1,000 MET-minutes/week) had a 12% lower risk of AF 
(adjusted hazard ratio [HR]: 0.88, 95% confidence interval [CI]: 0.80–0.97) than the inactive group. However, 
the insufficiently active group (1–500 MET-minutes/week; HR: 0.94, 95% CI: 0.86–1.03) and highly active group 
(≥1,000 MET-minutes/week; HR: 0.93, 95% CI: 0.85–1.03) had a modest but nonsignificant 6% and 7% lower 
risk of AF, respectively (Table 2).
Cox models with cubic splines showed a shape of the dose-response curve for the relationship between phys-
ical activity and risk of AF (P non-linearity = 0.08, Supplementary Fig. 2). Physical activity at volumes of about 
400–600 MET-minutes/week was associated with reduction for risk of AF. Physical activity volume over 1000 
MET-minutes/week was not related with risk of AF, however, its relative risk was not higher than inactivity.
Exercise intensity and AF. We employed separate moderate-intensity and vigorous-intensity categories 
ranging from 0 to >1,000 MET-minutes/week, and the analysis models were mutually adjusted for both LTPA 
Characteristic ALL
Physical activity level, MET min/week
None 1 to <500 500 to <1000 ≥1000 P for trend
Participants 501,690 125,259 (25.0%) 157,515 (31.4%) 132,823 (26.5%) 86,093 (17.2%)
Age 47.6 ± 14.3 50.4 ± 14.6 45.7 ± 13.9 46.5 ± 14.3 48.7 ± 13.9 <0.001
Female 250,664 (50.0%) 69,307 (55.3%) 81,601 (51.8%) 62,427(47.0%) 15,537 (42.6%) <0.001
BMI (kg/m2) 23.7 ± 3.3 23.7 ± 3.4 23.5 ± 3.4 23.7 ± 3.3 24.0 ± 3.1 <0.001
Waist circumflex 80.0 ± 9.4 80.2 ± 9.5 79.6 ± 9.5 80.0 ± 9.3 80.6 ± 8.9 <0.001
Heart failure 10,937 (2.2%) 3,798 (3.0%) 2,883 (1.8%) 2,458 (1.9%) 1,798 (2.1%) <0.001
Hypertension 107,925 (21.5%) 31,072 (24.8%) 29,056 (18.4%) 26,872 (20.2%) 20,925 (24.3%) 0.001
Diabetes 31,396 (6.3%) 8,590 (6.9%) 8,129 (5.2%) 8,037 (6.1%) 6,640 (7.7%) <0.001
Previous MI 4,555 (0.9%) 1,416 (1.1%) 1,177 (0.7%) 1,104 (0.8%) 858 (1.0%) 0.001
History of stroke/TIA 18,461 (3.7%) 5,986 (4.8%) 4,821 (3.1%) 4,404 (3.3%) 3,250 (3.8%) <0.001
Chronic kidney disease 29,265 (5.8%) 8,496 (6.8%) 8,104 (5.1%) 7,470 (5.6%) 5,195 (6.0%) <0.001
Dyslipidemia 143,497 (28.6%) 38,329 (31.0%) 42,371 (26.9%) 36,659 (27.6%) 26,138 (30.4%) <0.001
COPD 11,453 (2.3%) 3,841 (3.1%) 3,074 (2.0%) 2,639 (2.0%) 1,899 (2.2%) <0.001
Cancer 33,396 (6.7%) 9,065 (7.2%) 9,331 (5.9%) 8,421 (6.3%) 6,579 (7.6%) 0.003
Smoker (Ex or current) 188,985 (37.7%) 40,409 (32.3%) 58,690 (37.3%) 54,192 (40.8%) 35,694 (41.5%) <0.001
Alcohol drinker ( ≥ 1time/week) 236,772 (47.2%) 45,669 (36.5%) 77,592 (49.3%) 69,121 (52.0%) 44,390 (51.6%) <0.001
Systolic BP (mmHg) 122.3 ± 15.3 123.0 ± 15.9 121.3 ± 15.1 122.1 ± 15.1 123.1 ± 15.0 <0.001
Diastolic BP (mmHg) 76.1 ± 10.2 76.4 ± 10.4 75.7 ± 10.2 76.0 ± 10.1 76.5 ± 10.1 <0.001
Fasting glucose (mg/dl) 97.9 ± 24.8 98.9 ± 26.7 96.9 ± 23.5 97.5 ± 24.2 98.7 ± 25.1 <0.001
Total cholesterol (mg/dl) 194.9 ± 37.3 196.1 ± 38.1 194.7 ± 37.1 194.3 ± 36.9 194.7 ± 37.1 <0.001
Triglyceride 132.0 ± 93.9 136.0 ± 95.5 131.8 ± 93.6 130.7 ± 94.1 128.9 ± 91.5 <0.001
LDL (mg/dl) 113.7 ± 37.2 114.7 ± 38.9 113.4 ± 36.5 113.1 ± 36.6 113.6 ± 37.0 <0.001
HDL (mg/dl) 56.4 ± 27.2 56.7 ± 33.5 56.2 ± 25.3 56.3 ± 24.7 56.5 ± 24.0 <0.001
Table 1. Baseline characteristics stratified by the leisure-time physical activity level. Values are expressed as n 
(%) or means ± standard deviations. BMI: body mass index, BP: blood pressure, COPD: chronic obstructive 
pulmonary disease, HDL: high-density lipoprotein, LDL: low-density lipoprotein, MET: metabolic equivalent 
task, MI: myocardial infarction, TIA: transient ischemic attack.
Physical activity level, MET min/week
None 1 to <500 500 to <1000 ≥1000
Incidence (%) 1,084 (0.87%) 925 (0.59%) 796 (0.60%) 638 (0.74%)
Incidence (/1000 person-years) 2.27 1.52 1.56 1.91
Hazard ratio (95% confidence interval),
  Age and sex adjusted 1.00 (ref.) 0.94 (0.86–1.02) 0.88 (0.80–0.96) 0.94 (0.85–1.04)
  P value 0.145 0.005 0.211
  Fully adjusted† 1.00 (ref.) 0.94 (0.86–1.03) 0.88 (0.80–0.97) 0.93 (0.85–1.03)
  P value 0.165 0.007 0.172
Table 2. Risk of atrial fibrillation in relation to the total leisure-time physical activity. †The model was adjusted 
for age, sex, body mass index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke or 
transient ischemic attack, chronic kidney disease, smoking, and alcohol drinking. MET: metabolic equivalent task.
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intensities (Table 3). We found an AF risk reduction in moderate-intensity LTPA (500–1,000 MET-minutes/
week: HR: 0.90, 95% CI: 0.82–0.98). However, there was no reduction in the incidence of AF in vigorous-intensity 
LTPA. Even among the participants meeting the guideline-recommended LTPA level, the risk of AF sig-
nificantly decreased after performing moderate-intensity LTPA; the risk did not decrease after performing 
vigorous-intensity LTPA.
The participants who engaged in both moderate- and vigorous-intensity activities had no additional reduction 
in the AF risk compared with those who performed moderate-intensity activity alone. The adjusted relative risk 
of AF of the participants who had vigorous-intensity LTPA was insignificantly higher than that of those who had 
moderate-intensity LTPA (Fig. 2).
Subgroup analysis. The adjusted AF risk according to the total physical activity level in each subgroup is 
presented in Table 4. The association between physical activity level and AF risk was similar across the subgroups; 
the maximum benefit for AF risk reduction was associated with meeting the key target range of physical activity, 
with interactions indicating greater benefits in patients with blood pressures below 130/80 mmHg and without 
central obesity.
Discussion
The present study investigated the association between LTPA and development of AF in a nationwide general 
population. We assessed the effect of LTPA at different energy expenditures as indicated in public health guide-
lines for physical activity20,21. The key target range of physical activity (500–1,000 MET-minutes/week) was 
associated with the largest benefit for reduced AF risk in the general population, whereas insufficient activity 
Figure 1. Multivariable adjusted relative risk of atrial fibrillation according to physical activity level as classified 
in the Physical Activity Guidelines. †Minimum key guidelines target range in Physical Activity Guidelines for 
Americans by the U.S. Department of Health and Human Services (2018): Doing the equivalent of 500 to 1,000 
MET-minutes a week of physical activity. ‡Multivariable adjusted hazard ratio (HR): age, sex, BMI, HF, HTN, 
DM, Previous MI, Stroke or TIA, CKD, Smoking, and Alcohol.
Hazard ratio
(95% confidence interval)
Physical activity level, MET min/week
None 1 to <500 500 to <1000 ≥1000
Moderate
  Age and gender adjusted 1.00 (ref.) 0.96 (0.89–1.05) 0.89 (0.82–0.98) 0.88 (0.76–1.02)
  P value 0.383 0.014 0.095
  Fully adjusted† 1.00 (ref.) 0.96 (0.89–1.05) 0.90 (0.82–0.98) 0.88 (0.76–1.02)
  P value 0.393 0.018 0.082
Vigorous
  Age and gender adjusted 1.00 (ref.) 0.98 (0.89–1.07) 1.06 (0.93–1.21) 1.08 (0.93–1.25)
  P value 0.629 0.359 0.334
  Fully adjusted† 1.00 (ref.) 0.99 (0.90–1.08) 1.05 (0.93–1.20) 1.07 (0.92–1.23)
  P value 0.754 0.434 0.400
Table 3. Risk of atrial fibrillation according to the intensity of physical activity. †The model was adjusted for 
age, sex, body mass index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke 
or transient ischemic attack, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for 
both moderate- and vigorous-intensity activities. MET: metabolic equivalent task.
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(1–500 MET-minutes/week) and high activity (>1,000 MET-minutes/week) attenuated the benefit for AF risk 
reduction. Our analysis found an incremental reduction in incident AF after moderate-intensity physical activity; 
higher-intensity physical activity had no beneficial effect. The dose-response relationship between physical activ-
ity level and AF risk appeared to follow a U-shaped pattern.
Physical activity and AF. The health benefits of regular physical activity have been well described, including 
significant reductions in cardiovascular mortality and morbidity for those meeting the recommended key target 
range. Furthermore, an additional benefit occurred with increasing physical activity level. At the minimum rec-
ommended physical activity level, the risk of mortality, coronary heart disease, and heart failure decreased; at two 
times the minimum recommended level, the risk decreased further22,23.
In this nationwide population-based large cohort study, the subjects who met the key minimum recom-
mended target range by performing moderate- or vigorous-intensity LTPA had a 12% lower AF risk than the inac-
tive subjects. Those exceeding the key minimum recommended target range had no significant risk reduction. 
Our findings are consistent with those of previous studies supporting that moderate but not vigorous physical 
activity decreases the AF risk. However, a higher activity level did not significantly increase the risk of AF com-
pared with inactivity. The subjects who engaged in highly active LTPA did not appear to be at an increased risk of 
AF compared with those who had no LTPA. A meta-analysis including 18 cohort studies and one cross-sectional 
study reported that the dose-relationship between physical activity and AF had a J-shaped pattern, and a physical 
activity exceeding 1,200 MET-minutes/week was not associated with AF risk24. Some previous studies reported 
that increasing physical activity was probably associated with an increased risk of AF in men and a decreased risk 
in women25,26. However, our study did not find a gender-specific increased risk of AF with high volume physical 
activity. We believe the conflict results from different study populations. Previous studies reporting increased risk 
with higher physical activity level were mainly conducted among middle aged men or endurance athletes7,27,28, 
whereas our analyses conducted from general population with broad age. Zhu et al.25 meta-analysis reported that 
male individuals with intensive physical activity had a slightly higher risk of developing AF, but there was a sig-
nificantly reduced risk of incident AF in female. Interestingly, the meta-analysis showed that increasing physical 
activity was probably associated with an increased risk of AF in middle- or young-aged men. In addition, the 
meta-analysis included only western countries data. The pattern of risk for AF with increasing physical activity 
level vary according to study characteristics. Therefore, self-reported physical activity, widely varying categoriz-
ing of the activity, vary in definition of AF and different cultural patterns of sport seem to limit the comparative 
interpretation of existing studies29,30.
Interestingly, there was no difference in the cumulative incidence of AF between highly active and inactive 
groups in men (Supplementary Fig. 1,C), whereas highly active group had lower cumulative incidence of AF than 
in inactive group in women (Supplementary Fig. 1,D). It may support the hypothesis which was exercise-induced 
enhancement of parasympathetic tone dominate in men7. Our findings indicate the uncertainty of the nature of the 
relationship at higher physical activity levels and the complex role of physical activity in modifying the risk of AF.
There are several mechanisms underlying the complex association between physical activity and AF. Physical 
activity can potentially reduce the risk of AF through beneficial effects on cardiovascular risk factors. Conversely, 
long-term high exercise levels may lead to remodeling of the heart and alteration of the autonomic nervous system31.
Exercise intensity and AF. The current public health guideline did not specifically consider the rela-
tive value of different physical activity levels such as moderate- and vigorous-intensity physical activities32. In 
Figure 2. Joint association of moderate-intensity and vigorous-intensity physical activities with the adjusted 
relative risk of atrial fibrillation. †The multivariable adjusted hazard ratio was adjusted for age, sex, body mass 
index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke or transient ischemic 
attack, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for both moderate- and 
vigorous-intensity activities.
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the separate intensity model, the AF risk significantly decreased after moderate-intensity LTPA but not after 
vigorous-intensity LTPA. A small number of studies have reported the AF risk according to the intensity of 
physical activity. The relationship between exercise intensity and AF risk suggests a curvilinear response with 
Characteristic
Fully adjusted hazard ratio† (95% confidence interval)
Physical activity level, MET*min/week
None 1 to <500 500 to <1000 ≥1000 P for interaction
Age 0.210
  <50 1.00 (ref.) 0.93 (0.74–1.17) 0.81 (0.63–1.04) 0.81 (0.61–1.08)
  50 to 64 1.00 (ref.) 0.98 (0.84–1.15) 0.94 (0.80–1.11) 1.05 (0.89–1.23)
  ≥65 1.00 (ref.) 0.92 (0.82–1.04) 0.85 (0.78–0.97) 0.85 (0.74–0.98)
Sex 0.223
  Male 1.00 (ref.) 0.92 (0.81–1.03) 0.92 (0.81–1.03) 0.96 (0.85–1.09)
  Female 1.00 (ref.) 0.97 (0.85–1.10) 0.83 (0.72–0.96) 0.89 (0.75–1.05)
BMI 0.084
  <25 1.00 (ref.) 0.99 (0.88–1.11) 0.88 (0.78–0.99) 0.89 (0.78–1.02)
  ≥25 1.00 (ref.) 0.88 (0.77–1.02) 0.90 (0.78–1.04) 1.02 (0.88–1.19)
Central obesity by waist 0.033
  Yes 1.00 (ref.) 0.95 (0.83–1.08) 0.87 (0.76–1.003) 1.05 (0.90–1.22)
  No 1.00 (ref.) 0.94 (0.83–1.06) 0.89 (0.79–1.008) 0.87 (0.76–0.99)
Heart failure 0.622
  Yes 1.00 (ref.) 1.01 (0.79–1.28) 0.88 (0.67–1.15) 0.95 (0.71–1.27)
  No 1.00 (ref.) 0.93 (0.85–1.02) 0.88 (0.80–0.97) 0.92 (0.83–1.03)
Hypertension 0.193
  Yes 1.00 (ref.) 0.94 (0.84–1.06) 0.85 (0.75–0.96) 0.87 (0.76–0.99)
  No 0.95 (0.82–1.09) 0.93 (0.80–1.07) 1.00 (0.86–1.17)
High BP (>130/80 mmHg) 0.028
  Yes 1.00 (ref.) 0.98 (0.88–1.10) 0.93 (0.83–1.05) 1.01 (0.89–1.14)
  No 1.00 (ref.) 0.87 (0.75–1.01) 0.80 (0.68–0.93) 0.81 (0.69–0.96)
Diabetes 0.857
  Yes 1.00 (ref.) 1.03 (0.83–1.28) 0.87 (0.69–1.09) 0.92 (0.73–1.17)
  No 1.00 (ref.) 0.92 (0.84–1.02) 0.88 (0.80–0.98) 0.93 (0.84–1.04)
Chronic kidney disease 0.856
  Yes 1.00 (ref.) 1.05 (0.86–1.28) 0.83 (0.66–1.04) 0.98 (0.77–1.25)
  No 1.00 (ref.) 0.92 (0.83–1.01) 0.89 (0.80–0.98) 0.92 (0.82–1.02)
Previous MI 0.795
  Yes 1.00 (ref.) 0.98 (0.63–1.53) 0.67 (0.40–1.12) 0.93 (0.57–1.54)
  No 1.00 (ref.) 0.94 (0.86–1.03) 0.89 (0.81–0.98) 0.93 (0.84–1.03)
Dyslipidemia 0.752
  Yes 1.00 (ref.) 0.93 (0.81–1.05) 0.86 (0.75–0.98) 0.94 (0.81–1.08)
  No 1.00 (ref.) 0.96 (0.85–1.08) 0.91 (0.80–1.03) 0.93 (0.81–1.06)
CHDSV score‡
  0 1.00 (ref.) 0.96 (0.82–1.11) 0.95 (0.81–1.11) 1.0 (0.84–1.18) 0.216
  ≥1 1.00 (ref.) 0.94 (0.84–1.05) 0.84 (0.75–0.95) 0.88 (0.78–1.00)
  1~2 1.00 (ref.) 0.94 (0.83–1.07) 0.84 (0.74–0.96) 0.89 (0.77–1.02)
  ≥3 1.00 (ref.) 0.93 (0.73–1.19) 0.84 (0.65–1.09) 0.85 (0.63–1.13)
Alcohol (≥1time/week) 0.078
  Drinker 1.00 (ref.) 0.94 (0.80–1.10) 0.95 (0.81–1.11) 1.03 (0.87–1.21)
  Non-drinker 1.00 (ref.) 0.95 (0.85–1.06) 0.85 (0.76–0.95) 0.87 (0.76–0.99)
Smoking (former + current) 0.888
  Smoker 1.00 (ref.) 0.99 (0.85–1.15) 0.91 (0.79–1.06) 0.93 (0.79–1.09)
  Never 1.00 (ref.) 0.91 (0.82–1.02) 0.86 (0.77–0.97) 0.94 (0.83–1.07)
Table 4. Association between increasing physical activity level and risk of atrial fibrillation according to 
subgroups. †The model was adjusted for age, sex, BMI, heart failure, hypertension, diabetes, previous MI, prior 
stroke or TIA, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for both moderate- 
and vigorous-intensity activities. ‡CHDSV score assigns 1 point for heart failure, hypertension, diabetes, prior 
stroke or TIA, and vascular disease. BMI: body mass index, BP: blood pressure, MET: metabolic equivalent task, 
MI: myocardial infarction, TIA: transient ischemic attack.
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diminishing benefit or even a risk with the most intense exercise33. Mozaffarian et al. reported that a signifi-
cant reduction in the AF risk could be observed with moderate- but not high-intensity exercise6. Similarly, a 
Norwegian community-based cohort study reported that a significant reduction in the AF risk could be observed 
with moderate-intensity activities such as walking and cycling, but not higher-intensity activities30. We believe our 
data are of interest because they expand our understanding of the complex role of physical activity in modifying 
the risk of AF in the general population. Moderate physical activity may reduce the risk of AF via modified cardio-
vascular risk factors, e.g., by improving weight, blood pressure, inflammation, glucose level, and lipid control34–36.
However, this favorable effect of moderate physical activity on AF may be mitigated by chronic exposure to 
vigorous physical activity, which generates structural and functional cardiac adaptations that hinder the reduction 
of the risk of AF. The possible mechanism of the increased AF risk in subjects exposed to vigorous physical activ-
ity may be higher inflammation and oxidative stress37, increased atrial ectopic burden38, vagal enhancement39, 
and atrial dilatation and fibrosis40. These mechanisms are widely documented in long-endurance training and 
could counteract the beneficial effect of moderate physical activity on the AF risk41. Further studies designed to 
measure physical activity exposure in terms of energy expenditure are needed to clarify the relationship between 
different intensities of physical activity and AF risk.
A major strength of this study is its large sample size with a broad age range from a representative nationwide 
cohort, and that the uniform physical activity categories used matched the levels described in the current public 
guidelines. In addition, limited data are available to evaluate the AF in relation to LTPA in Asian population. 
To the best of our knowledge, this was the largest Asian population-based study investigating the association 
between physical activity and AF. However, some limitations must also be considered.
Study limitations. The limitations of this study include the reliance on the self-reported physical activity, 
which was reported at a single time point. This may cause inaccurate measurements of self-reported LTPA hab-
its, and the conditions at the time of questionnaire completion may not represent the actual LTPA conditions 
throughout life. Further, behavioral changes during the follow-up period could not be assessed in our study. 
Nevertheless, self-report questionnaires may provide a reliable approximation of PA at a population level42, and 
validity of IPAQ based self-reported physical activity questionnaire has been confirmed in several studies and has 
yielded valuable results to date43. In addition, although the South Korean society has changed radically and has 
become more westernized, caution is needed for generalization of our results to western countries owing to racial, 
ethnic, and geographic restrictions. This study is potentially susceptible to errors arising from coding inaccura-
cies and cases of asymptomatic paroxysmal AF may have been missed because the research used administrative 
database. To minimize this problem, we applied the definition that we already validated in previous studies that 
used the Korean NHIS sample cohort and the diagnostic reliability of cohort data was high12–15. The validity of 
hazard ratios depend on the completeness of follow-up because the analysis was performed retrospectively. The 
NHIS in Korea is a universal coverage and single-insurer system, we believe that very small participants were lost 
to follow-up. Unfortunately, we were unable to adjust for variables that were not included in the cohort, such as 
occupational physical activity, echocardiogram and obstructive sleep apnea data.
conclusions
Meeting the recommended key target range of physical activity was associated with the maximum benefit for AF 
risk reduction in the general population. The dose-response relationship between physical activity level and AF 
risk showed a U-shaped pattern. Although exceeding the key target range attenuated this benefit, it did not increase 
the risk of AF beyond that during inactivity. Our findings support the current public guideline-recommended 
150-minute/week moderate-intensity physical activity for achieving health benefits. Although vigorous 
LTPA should not be discouraged for those who want a higher intensity of activity, our results indicate that 
moderate-intensity exercise is more recommended to achieve substantial health benefits for AF risk reduction.
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